Prevalence of HPV after introduction of the vaccination program in the United States
LE Markowitz, G Liu, S Hariri, M Steinau, EF Dunne… - …, 2016 - publications.aap.org
BACKGROUND: Since mid-2006, human papillomavirus (HPV) vaccination has been
recommended for females aged 11 to 12 years and through 26 years if not previously …
recommended for females aged 11 to 12 years and through 26 years if not previously …
Human papillomavirus vaccine effectiveness and herd protection in young women
C Spinner, L Ding, DI Bernstein, DR Brown… - …, 2019 - publications.aap.org
BACKGROUND: Clinical trials of the 4-valent human papillomavirus (HPV) vaccine
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …
demonstrate high efficacy, but surveillance studies are essential to examine the long-term …
Ten years of human papillomavirus vaccination in the United States
LE Markowitz, J Gee, H Chesson, S Stokley - Academic pediatrics, 2018 - Elsevier
Since human papillomavirus (HPV) vaccine was first introduced for females in the United
States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed …
States in 2006, vaccination policy has evolved as additional HPV vaccines were licensed …
Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction
JA Kahn, DR Brown, L Ding, LE Widdice, ML Shew… - …, 2012 - publications.aap.org
OBJECTIVES: The aims of this study were to compare prevalence rates of human
papillomavirus (HPV) in young women before and after HPV vaccine introduction to …
papillomavirus (HPV) in young women before and after HPV vaccine introduction to …
An update on human papillomavirus vaccine uptake among 11–17 year old girls in the United States: National Health Interview Survey, 2010
TH Laz, M Rahman, AB Berenson - Vaccine, 2012 - Elsevier
PURPOSE: A 3-dose human papillomavirus (HPV) vaccine is recommended for adolescents
to protect against HPV-related cervical and other cancers. The purpose of this study was to …
to protect against HPV-related cervical and other cancers. The purpose of this study was to …
Population impact of HPV vaccines: summary of early evidence
S Hariri, LE Markowitz, EF Dunne, ER Unger - Journal of Adolescent Health, 2013 - Elsevier
Human papillomavirus (HPV) vaccines are available in the United States and around the
world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV …
world to prevent HPV-associated diseases including cervical cancer and genital warts. HPV …
4-valent human papillomavirus (4vHPV) vaccine in preadolescents and adolescents after 10 years
DG Ferris, R Samakoses, SL Block… - …, 2017 - publications.aap.org
OBJECTIVES: We describe the final 10-year data for the long-term follow-up study of the 4-
valent human papillomavirus (4vHPV) vaccine in preadolescents and adolescents …
valent human papillomavirus (4vHPV) vaccine in preadolescents and adolescents …
HPV vaccine and adolescent males
In 2009, the United States approved quadrivalent HPV vaccine for males 9–26 years old, but
data on vaccine uptake are lacking. We determined HPV vaccine uptake among adolescent …
data on vaccine uptake are lacking. We determined HPV vaccine uptake among adolescent …
Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey
R Caskey, ST Lindau, GC Alexander - Journal of Adolescent Health, 2009 - Elsevier
PURPOSE: In 2006, universal human papillomavirus (HPV) vaccination of females ages 9 to
26 years became a formal recommendation, yet little is known about knowledge and …
26 years became a formal recommendation, yet little is known about knowledge and …
Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition …
LE Markowitz, S Hariri, C Lin, EF Dunne… - The Journal of …, 2013 - academic.oup.com
Background. Human papillomavirus (HPV) vaccination was introduced into the routine
immunization schedule in the United States in late 2006 for females aged 11 or 12 years …
immunization schedule in the United States in late 2006 for females aged 11 or 12 years …